<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01312038</url>
  </required_header>
  <id_info>
    <org_study_id>PRO011010385</org_study_id>
    <nct_id>NCT01312038</nct_id>
  </id_info>
  <brief_title>Effect of Simethicone on Eustachian Tube Dysfunction</brief_title>
  <official_title>A Pilot Study of the Effect of Simethicone in Adult Subjects With a Common Cold on Eustachian Tube Dysfunction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to measure the effects of a chewable Simethicone tablet taken by mouth
      on middle-ear pressure in adults with a common cold and evidence of abnormal middle-ear
      pressure. In children and adults, middle-ear diseases such as otitis media (the buildup of
      fluid within the middle ear) and a form of temporary hearing loss occur if the Eustachian
      tube does not open, does not open often enough or is always open. Simethicone, available
      over-the-counter under several brand names including Gas-X, may help break up the bubbles
      that may block the opening of the Eustachian tube in the back of the nose during a cold,
      allowing air to pass between the nose and middle ear. This study requires a single visit to
      the Middle Ear Physiology Laboratory in the Oakland section of Pittsburgh. If eligible for
      the study, Eustachian tube function testing will be done; the Simethicone tablet or placebo
      (a tablet that looks and tastes like the Simethicone tablet but has no active ingredient)
      will be given and Eustachian tube function testing repeated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For the Eustachian tube function testing, the subject and a technician are seated comfortably
      within a pressure chamber, a room-like chamber in which the air pressure can be varied much
      like in an airplane or submarine. Middle ear pressure will be measured in each ear by
      tympanometry, a test done by inserting a small probe (an earplug attached to a rubber or
      plastic tube that measures ear pressure) half-way into the ear canal and changing the
      pressure in the probe. Then, microphones will be placed in the ear canals and a sound source
      placed into one nostril. The chamber pressure is then decreased and increased to various
      pressures and middle ear pressure is measured at these various pressures.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fraction of Middle Ear (ME) Pressure Equilibrated (FGE)</measure>
    <time_frame>After achieving the desired ME-pressure chamber gradient at baseline and 30 min post treatment</time_frame>
    <description>The proportion of the pressure chamber-ME pressure gradient equilibrated with 1 swallow</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Otitis Media</condition>
  <arm_group>
    <arm_group_label>simethicone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>125 mg tablet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>chewable calcium tablet</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Simethicone</intervention_name>
    <description>single 125 mg chewable tablet</description>
    <arm_group_label>simethicone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>chewable calcium tablet</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 to 50 years

          -  Healthy subjects other than current upper respiratory tract infection (&quot;cold&quot;)

          -  Jackson Score of 6 on screening

          -  Subject reports symptom onset within 4 days of entry visit

          -  Unilateral or bilateral middle-ear pressure &lt;-50 mmH2O

        Exclusion Criteria:

          -  Otoscopic diagnosis of unilateral or bilateral otitis media

          -  Presence of tympanostomy tubes or tympanic membrane perforations bilaterally

          -  Asthma or any chronic medical disease or condition

          -  Use of an &quot;over the counter&quot; medicine within 24 hours of study or prescription within
             4 weeks of the study day (except birth control)

          -  Use of an experimental drug within 3 months of study

          -  An unusual or allergic reaction to simethicone, food dyes, or preservatives

          -  Pregnancy or breast feeding

          -  Ear surgery other than tympanostomy tube insertion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William J Doyle, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Otolaryngology, Children's Hospital of Pittsburgh of UPMC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Middle Ear Physiology Laboratory of Children's Hospital of PIttsburgh of UPMC</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 9, 2011</study_first_submitted>
  <study_first_submitted_qc>March 9, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 10, 2011</study_first_posted>
  <results_first_submitted>February 19, 2016</results_first_submitted>
  <results_first_submitted_qc>June 23, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 27, 2016</results_first_posted>
  <last_update_submitted>June 23, 2016</last_update_submitted>
  <last_update_submitted_qc>June 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>William J. Doyle</investigator_full_name>
    <investigator_title>Professor of Otolaryngology</investigator_title>
  </responsible_party>
  <keyword>Eustachian tube</keyword>
  <keyword>otitis</keyword>
  <keyword>middle-ear pressure</keyword>
  <keyword>simethicone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Otitis</mesh_term>
    <mesh_term>Otitis Media</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Simethicone</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment began in March 2011 and was terminated in March 2013. Recruitment was done by advertisement in the community.</recruitment_details>
      <pre_assignment_details>Ninety subjects (31 males, 59 females)were screened; 25 subjects entered the randomization phase.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Simethicone</title>
          <description>125 mg tablet
Simethicone: single 125 mg chewable tablet</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>chewable calcium tablet
Placebo: chewable calcium tablet</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Analysis done by ears with evaluable tests.</population>
      <group_list>
        <group group_id="B1">
          <title>Simethicone</title>
          <description>125 mg tablet
Simethicone: single 125 mg chewable tablet</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>chewable calcium tablet
Placebo: chewable calcium tablet</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="13"/>
            <count group_id="B2" value="12"/>
            <count group_id="B3" value="25"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.1" spread="9.1"/>
                    <measurement group_id="B2" value="32.8" spread="11.7"/>
                    <measurement group_id="B3" value="29.8" spread="10.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Fraction of Middle Ear (ME) Pressure Equilibrated (FGE)</title>
        <description>The proportion of the pressure chamber-ME pressure gradient equilibrated with 1 swallow</description>
        <time_frame>After achieving the desired ME-pressure chamber gradient at baseline and 30 min post treatment</time_frame>
        <population>ears pre-treatment/ears post-treatment</population>
        <group_list>
          <group group_id="O1">
            <title>Simethicone-treated</title>
            <description>Outcome measure in each evaluable ear.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Outcome measure in each evaluable ear</description>
          </group>
        </group_list>
        <measure>
          <title>Fraction of Middle Ear (ME) Pressure Equilibrated (FGE)</title>
          <description>The proportion of the pressure chamber-ME pressure gradient equilibrated with 1 swallow</description>
          <population>ears pre-treatment/ears post-treatment</population>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>ears</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre treatment FGE at -200 daPa</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.17" spread="0.28"/>
                    <measurement group_id="O2" value="0.24" spread="0.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post-treatment FGE at -200 daPa</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.19" spread="0.28"/>
                    <measurement group_id="O2" value="0.23" spread="0.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pre -treatment FGE at 200 daPa</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.24" spread="0.31"/>
                    <measurement group_id="O2" value="0.30" spread="0.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-treatment FGE at 200 daPa</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.24" spread="0.29"/>
                    <measurement group_id="O2" value="0.34" spread="0.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison of the simethicone and placebo groups with respect to the difference between the pre-post treatment FGE at ME-pressure chamber gradient of -200 daPa.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>=0.93</p_value>
            <method>Paired T-test</method>
            <method_desc>df=34</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison of the simethicone and placebo groups with respect to the difference between the pre-post treatment FGE at ME-pressure chamber gradient of 200 daPa.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>=0.39</p_value>
            <method>Paired T-test</method>
            <method_desc>df = 31</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>The subjects were assessed throughout the experimental procedure which lasted for 2 hours.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Simethicone</title>
          <description>125 mg tablet
Simethicone: single 125 mg chewable tablet</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>chewable calcium tablet
Placebo: chewable calcium tablet</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Ellen Mandel, MD</name_or_title>
      <organization>Middle Ear Physiology Laboratory</organization>
      <phone>412-692-6214</phone>
      <email>mandele@pitt.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

